Jeil Pharmaceutical Co.,Ltd (KRX:271980)

South Korea · Delayed Price · Currency is KRW

14,790

+110 (0.75%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Pharmaceutical Business Division	695.54B	705.34B	722.23B	700.69B	691.32B
Pharmaceutical Business Division Growth	-1.39%	-2.34%	3.07%	1.36%	2.97%
Research & Developent Division	9.01B	21.06B	-	-	-
Research & Developent Division Growth	-57.23%	-	-	-	-
Total	704.54B	726.39B	722.23B	700.69B	691.32B
Total Growth	-3.01%	0.58%	3.07%	1.36%	2.97%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
South Korea	665.14B	684.74B	696.77B	679.37B	661.45B
South Korea Growth	-2.86%	-1.73%	2.56%	2.71%	3.63%
Overseas	39.40B	41.65B	25.46B	21.32B	29.87B
Overseas Growth	-5.41%	63.59%	19.43%	-28.64%	-9.73%
Total	704.54B	726.39B	722.23B	700.69B	691.32B
Total Growth	-3.01%	0.58%	3.07%	1.36%	2.97%

Source: S&P Global Market Intelligence.